| GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients P Humaidan, NP Polyzos, B Alsbjerg, K Erb, AL Mikkelsen, HO Elbaek, ... Human Reproduction 28 (9), 2511-2521, 2013 | 264 | 2013 |
| The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives P Humaidan, EG Papanikolaou, D Kyrou, B Alsbjerg, NP Polyzos, ... Reproductive biomedicine online 24 (2), 134-141, 2012 | 130 | 2012 |
| Pregnancy loss after frozen-embryo transfer—a comparison of three protocols C Tomás, B Alsbjerg, H Martikainen, P Humaidan Fertility and sterility 98 (5), 1165-1169, 2012 | 114 | 2012 |
| Progesterone levels on pregnancy test day after hormone replacement therapy-cryopreserved embryo transfer cycles and related reproductive outcomes B Alsbjerg, L Thomsen, HO Elbaek, R Laursen, BB Povlsen, T Haahr, ... Reproductive biomedicine online 37 (5), 641-647, 2018 | 105 | 2018 |
| Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone … HM Fatemi, NP Polyzos, I Van Vaerenbergh, C Bourgain, C Blockeel, ... Fertility and sterility 100 (3), 742-747. e1, 2013 | 87 | 2013 |
| Increasing vaginal progesterone gel supplementation after frozen–thawed embryo transfer significantly increases the delivery rate B Alsbjerg, NP Polyzos, HO Elbaek, BB Povlsen, CY Andersen, ... Reproductive biomedicine online 26 (2), 133-137, 2013 | 71 | 2013 |
| GnRHa trigger for final oocyte maturation: is HCG trigger history? P Humaidan, B Alsbjerg Reproductive BioMedicine Online 29 (3), 274-280, 2014 | 67 | 2014 |
| Vaginal microbiota and in vitro fertilization outcomes: development of a simple diagnostic tool to predict patients at risk of a poor reproductive outcome T Haahr, P Humaidan, HO Elbaek, B Alsbjerg, RJ Laursen, K Rygaard, ... The Journal of Infectious Diseases 219 (11), 1809-1817, 2019 | 58 | 2019 |
| PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome JL Yovich, B Alsbjerg, JL Conceicao, PM Hinchliffe, KN Keane Drug design, development and therapy, 2561-2573, 2016 | 54 | 2016 |
| Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles P Humaidan, I Van Vaerenbergh, C Bourgain, B Alsbjerg, C Blockeel, ... Human reproduction 27 (11), 3259-3272, 2012 | 53 | 2012 |
| Fertility preservation and refreezing of transplanted ovarian tissue—a potential new way of managing patients with low risk of malignant cell recurrence SG Kristensen, V Giorgione, P Humaidan, B Alsbjerg, AMB Bjørn, E Ernst, ... Fertility and sterility 107 (5), 1206-1213, 2017 | 51 | 2017 |
| Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial CY Andersen, HO Elbaek, B Alsbjerg, RJ Laursen, BB Povlsen, ... Human reproduction 30 (10), 2387-2395, 2015 | 51 | 2015 |
| Dual stimulation using corifollitropin alfa in 54 Bologna criteria poor ovarian responders–a case series B Alsbjerg, T Haahr, HO Elbaek, R Laursen, BB Povlsen, P Humaidan Reproductive biomedicine online 38 (5), 677-682, 2019 | 50 | 2019 |
| Can combining vaginal and rectal progesterone achieve the optimum progesterone range required for implantation in the HRT-FET model? B Alsbjerg, L Thomsen, HO Elbaek, R Laursen, BB Povlsen, T Haahr, ... Reproductive Biomedicine Online 40 (6), 805-811, 2020 | 37 | 2020 |
| The combined effect of lifestyle intervention and antioxidant therapy on sperm DNA fragmentation and seminal oxidative stress in IVF patients: a pilot study P Humaidan, T Haahr, BB Povlsen, L Kofod, RJ Laursen, B Alsbjerg, ... International braz j urol 48, 131-156, 2022 | 33 | 2022 |
| GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients P Humaidan, LH Thomsen, B Alsbjerg Human Reproduction 28 (9), 2593-2594, 2013 | 29 | 2013 |
| The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors S Kol, P Humaidan, B Alsbjerg, L Engmann, C Benadiva, ... Reproductive BioMedicine Online 30 (6), 563-565, 2015 | 22 | 2015 |
| The gonadotropin‐releasing hormone antagonist protocol–the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation S Kol, R Homburg, B Alsbjerg, P Humaidan Acta obstetricia et gynecologica Scandinavica 91 (6), 643-647, 2012 | 22 | 2012 |
| Motivational interviewing: a part of the weight loss program for overweight and obese women prior to fertility treatment K Karlsen, P Humaidan, LH Sørensen, B Alsbjerg, P Ravn Gynecological endocrinology 29 (9), 839-842, 2013 | 20 | 2013 |
| Case of successful IVF treatment of an oligospermic male with 46, XX/46, XY chimerism RJ Laursen, B Alsbjerg, I Vogel, CH Gravholt, H Elbaek, DL Lildballe, ... Journal of Assisted Reproduction and Genetics 35, 1325-1328, 2018 | 16 | 2018 |
